NRAL and hepatocellular carcinoma: Further investigation showed that NRAL unites with miR-340-5p through endogenous "sponge", up-regulates its target Nrf2 expression, activates Nrf2-dependent antioxidant pathway leading to CDDP resistance in HCC cells 124.